Ellen Honisch

Duesseldorf, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction.

Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction.

Journal: Breast cancer research : BCR

Published: August 12, 2024

Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction.

Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction.

Journal: medRxiv : the preprint server for health sciences

Published: February 27, 2024

Limitations in next-generation sequencing-based genotyping of breast cancer polygenic risk score loci.

Limitations in next-generation sequencing-based genotyping of breast cancer polygenic risk score loci.

Journal: European journal of human genetics : EJHG

Published: December 21, 2023

A workflow for the enrichment, the identification, and the isolation of non-apoptotic single circulating tumor cells for RNA sequencing analysis.

A workflow for the enrichment, the identification, and the isolation of non-apoptotic single circulating tumor cells for RNA sequencing analysis.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology

Published: August 29, 2023

Whole Exome Analysis to Select Targeted Therapies for Patients with Metastatic Breast Cancer - A Feasibility Study.

Whole Exome Analysis to Select Targeted Therapies for Patients with Metastatic Breast Cancer - A Feasibility Study.

Journal: Geburtshilfe und Frauenheilkunde

Published: April 30, 2023

A novel cancer risk prediction score for the natural course of FA patients with biallelic BRCA2/FANCD1 mutations.

A novel cancer risk prediction score for the natural course of FA patients with biallelic BRCA2/FANCD1 mutations.

Journal: Human molecular genetics

Published: September 06, 2022

Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.

Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.

Journal: Communications biology

Published: November 15, 2021

Multiparametric Circulating Tumor Cell Analysis to Select Targeted Therapies for Breast Cancer Patients.

Multiparametric Circulating Tumor Cell Analysis to Select Targeted Therapies for Breast Cancer Patients.

Journal: Cancers

Published: October 22, 2021

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness.

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness.

Journal: Cancer research

Published: July 01, 2019

EZH2 Loss Drives Resistance to Carboplatin and Paclitaxel in Serous Ovarian Cancers Expressing ATM.

EZH2 Loss Drives Resistance to Carboplatin and Paclitaxel in Serous Ovarian Cancers Expressing ATM.

Journal: Molecular cancer research : MCR

Published: February 04, 2019

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.

Journal: Human mutation

Published: January 30, 2019

Detection of circulating tumor cells in colorectal cancer patients using the GILUPI CellCollector: results from a prospective, single-center study.

Detection of circulating tumor cells in colorectal cancer patients using the GILUPI CellCollector: results from a prospective, single-center study.

Journal: Molecular oncology

Published: January 20, 2019

Showing 1-12 of 23

Last Updated: 09/26/2026